Headquarters
49 RUE DES NOUVELLES, SURESNES, ILE-DE-FRANCE 92150, FR
SURESNES, ILE-DE-FRANCE, FR
ALGOTHERAPEUTIX
From the company
AlgoTherapeutix (AlgoTx) is a clinical stage biotechnology company developing targeted, first in class therapeutics for peripheral neuropathic pain. Its lead asset, ATX01, is a non-opioid, locally acting agent that inhibits specific nociceptive sodium channels. ATX01's lead indication is Chemotherapy-Induced Peripheral Neuropathy (CIPN), and it is in Phase 2 clinical development.
Products & services offered
Capabilities 2
Facilities
Send your requirements
Quantities, certifications, and timing.